You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
20 November 2017
PledPharma and Solasia enter license agreement to develop and commercialize PledOx(r) in Asia
26 June 2015
PLEDPHARMA PRESENTS ADDITIONAL RESULTS FROM A PHASE IIB STUDY WITH PLEDOX® AT THE SCIENTIFIC CONFERENCE MASCC
21 April 2015
Interim report first quarter 2015
29 March 2015
PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX(r) REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT
PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX® REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT
17 February 2015
Year-end report 2014